52 related articles for article (PubMed ID: 38440862)
1. Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the Multiple Myeloma Group.
Fazio F; Passucci M; Micozzi J; Di Landro F; Fianchi L; Za T; Manieri VM; Annibali O; Cupelli L; Bongarzoni V; Gentili S; De Padua L; Crisanti E; Garzia MG; Rago A; Piciocchi A; Mengarelli A; Morè S; De Stefano V; Bafti MS; Martelli M; Petrucci MT
Bone Marrow Transplant; 2024 Jun; 59(6):896-898. PubMed ID: 38461292
[No Abstract] [Full Text] [Related]
2. Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab.
Abdallah N; Murray D; Dispenzieri A; Kapoor P; Gertz MA; Lacy MQ; Hayman SR; Buadi FK; Gonsalves W; Muchtar E; Leung N; Dingli D; Kourelis T; Warsame R; Binder M; Kyle RA; Rajkumar SV; Kumar S
Leukemia; 2022 May; 36(5):1426-1428. PubMed ID: 35091659
[No Abstract] [Full Text] [Related]
3. Darzalex (Daratumumab): First Anti-CD38 Monoclonal Antibody Approved for Patients with Relapsed Multiple Myeloma.
Raedler LA
Am Health Drug Benefits; 2016 Mar; 9(Spec Feature):70-3. PubMed ID: 27668047
[No Abstract] [Full Text] [Related]
4. Impact of Daratumumab on Stem Cell Mobilization and Transplant in Patient with Newly Diagnosed Multiple Myeloma: A Real Word Single-Centre Study.
Passucci M; Fazio F; Micozzi J; Bafti MS; Assanto G; Piciocchi A; Martelli M; Petrucci MT
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024041. PubMed ID: 38882459
[No Abstract] [Full Text] [Related]
5. Daratumumab maintenance in patients with myeloma.
Beksac M
Lancet Oncol; 2024 Jun; ():. PubMed ID: 38889736
[No Abstract] [Full Text] [Related]
6. Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab.
Abdallah N; Murray D; Dispenzieri A; Kapoor P; Gertz MA; Lacy MQ; Hayman SR; Buadi FK; Gonsalves W; Muchtar E; Leung N; Dingli D; Kourelis T; Warsame R; Binder M; Kyle RA; Rajkumar SV; Kumar S
Leukemia; 2024 Jun; ():. PubMed ID: 38886491
[No Abstract] [Full Text] [Related]
7. Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study.
Kumar L; Melinkeri S; Ganesan P; Kumar J; Biswas G; Kilara N; Pathalingappa H; Prasad S; Jain M; Mishra SK; Prasad S; Boyella PK; Sahoo RK; Bondarde S; Shah S; Rege M; Deb U; Korde T; Dixit J
Future Oncol; 2024 Feb; 20(4):191-205. PubMed ID: 38116642
[TBL] [Abstract][Full Text] [Related]
8. Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.
Palumbo A; Chanan-Khan A; Weisel K; Nooka AK; Masszi T; Beksac M; Spicka I; Hungria V; Munder M; Mateos MV; Mark TM; Qi M; Schecter J; Amin H; Qin X; Deraedt W; Ahmadi T; Spencer A; Sonneveld P;
N Engl J Med; 2016 Aug; 375(8):754-66. PubMed ID: 27557302
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of anti-CD38 isatuximab plus pomalidomide and dexamethasone in five relapsed myeloma patients with prior exposure to anti-C38 daratumumab: case series.
Djebbari F; Poynton M; Sangha G; Anderson L; Maddams R; Eyre TA; Vallance G; Basu S; Ramasamy K
Hematology; 2022 Dec; 27(1):204-207. PubMed ID: 35134321
[No Abstract] [Full Text] [Related]
10. Transient Daratumumab-Induced Refractive Shift in Multidrug-Resistant Multiple Myeloma: Case Report and Literature Review.
Troisi S; Giudice V; Troisi M; Morini D; Crudele A; Cuffa B; Selleri C; Serio B
Acta Haematol; 2023; 146(5):424-430. PubMed ID: 37331348
[TBL] [Abstract][Full Text] [Related]
11. Daratumumab for the treatment of multiple myeloma.
Touzeau C; Moreau P
Expert Opin Biol Ther; 2017 Jul; 17(7):887-893. PubMed ID: 28434255
[TBL] [Abstract][Full Text] [Related]
12. A rare case of daratumumab-associated encephalopathy in multiple myeloma.
Xiang J; Hong Z; Zhang Y; Chen J; Shen J; Zhu N
Immunotherapy; 2024 Apr; 16(7):447-452. PubMed ID: 38440862
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
